The Liquid Biopsy and Tumor Progression in Breast Cancer
1 – 10 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma (
- Barriers and facilitators for individualized rehabilitation during breast cancer treatment- A focus group study exploring health care professionals' experiences (
- The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response (
- Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer (
- Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017 (
- Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting (
- The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome (
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma (
- Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer (
- Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression (